Where Patients, Doctors
and Biotechnology Meet.
"Biotechnology is continuously improving our ability to diagnose diseases".
Noel Silva, CEO.
The in vitro diagnostics (IVD) market (a subset of the overall medical technology market — which focuses on molecular diagnostics for conditions like infectious diseases, chronic diseases, sexually-transmitted diseases (STDs), oncology, and genetic testing) was valued at almost $50 billion in 2012 and expected to reach nearly $70 billion by 2017 according to a report by Research and Markets.
Identify novel global Allergy and Immunology in vitro diagnostic opportunities while lowering the cost of health care and provide faster and better diagnostic services to the physician community.
To be the partner of choice for development and commercialization of novel diagnostic assays.
CDG Biotech Corp identifies the highest levels of quality as its main objective to achieve total customer satisfaction. As such, CDG Biotech Corp has implemented and will sustain a quality system which complies with customer, supplier, internal and regulatory requirements.
Our organization shall focus on continuous improvement and customer satisfaction as a strategic imperative. We will periodically review our quality management system to ensure compliance with the current standards according to the guidelines established by regulatory agencies.
We have state of the art facilities in Westlake Village, CA.